BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Thermal Gradient, Inc. Announces Manufacture of Next Generation DNA Testing Device


6/27/2012 11:24:38 AM

ROCHESTER, N.Y., June 26, 2012 /PRNewswire/ -- Thermal Gradient, Inc., a developer of disposable ultra-fast DNA testing devices, announced today that it has initiated the manufacture of its next generation device. Robert Juncosa, the company's Chief Technology Officer stated, "Our previous generation device was a huge success. It performs PCR, the critical step in almost all DNA tests, in less than eight minutes. This new device is capable of "real-time" PCR, a process used to determine the amount of initial DNA being tested. This is very important when testing for infectious diseases like HIV."

Because of design improvements over the previous generation, the new device will is expected to perform better but will cost less to manufacture.

"Our recent breakthroughs and this new device position us as the premier technology for both point of care and high throughput clinical laboratory testing," says CEO Joel Grover. "Because of our speed, low cost, and fundamental design, the hardware module required to perform a quantitative DNA test is small. This makes it easily scalable to achieve high throughput systems in a modest instrument footprint."

The company will begin testing the new devices in the third quarter. Dr. Grover added, "When our internal testing is complete, we will then make cartridges and demonstration platforms available to diagnostic systems developers for their evaluation and assay optimization."

About Thermal Gradient
Thermal Gradient develops devices and systems based on its patented technology that enables nucleic acid testing to be performed in minutes instead of an hour or more. Systems based on this technology can be developed for clinics and remote settings as well as for main-line diagnostic platforms for the clinical laboratory. For more information, please visit:
www.thermalgradient.com

Contact:
Joel Grover, Ph.D
Chief Executive Officer
Thermal Gradient, Inc.
585-248-9598
info@thermalgradient.com

SOURCE Thermal Gradient



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES